Age-related changes in natural killer cell repertoires: impact on NK cell function and immune surveillance

Cancer Immunology, Immunotherapy

Volumn 65, Issue 4, 2016, Pages 417-426

  Manser, Angela R ^a   Uhrberg, Markus ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Aging; KIR; Natural killer cell; NKG2

Indexed keywords

NATURAL KILLER CELL RECEPTOR NKG2A; NATURAL KILLER CELL RECEPTOR;

AGING; ARTICLE; CELL DIFFERENTIATION; CELL MATURATION; CELL PROLIFERATION; CYTOTOXIC T LYMPHOCYTE; DOWN REGULATION; HLA SYSTEM; HUMAN; HUMAN CYTOMEGALOVIRUS; IMMUNOSURVEILLANCE; MYELODYSPLASTIC SYNDROME; NATURAL KILLER CELL; PHENOTYPE; PRIORITY JOURNAL; UPREGULATION; ADOLESCENT; ADULT; AGE; AGED; CHILD; IMMUNOLOGY; INFANT; METABOLISM; MIDDLE AGED; NEWBORN; PRESCHOOL CHILD; VERY ELDERLY;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; AGING; CHILD; CHILD, PRESCHOOL; HUMANS; IMMUNOLOGIC SURVEILLANCE; INFANT; INFANT, NEWBORN; KILLER CELLS, NATURAL; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; RECEPTORS, NATURAL KILLER CELL;

EID: 84939516469     PISSN: 03407004     EISSN: 14320851     Source Type: Journal    
DOI: 10.1007/s00262-015-1750-0     Document Type: Article

References (56)

1. WHO Globocan (2008) Cancer incidence and mortality worldwide. http://globocan.iarc.fr. Accessed 22 April 2015
2. Fulop T, Larbi A, Pawelec G (2013) Human T cell aging and the impact of persistent viral infections. Front Immunol 4:271. doi:10.3389/fimmu.2013.00271
3. Linton PJ, Dorshkind K (2004) Age-related changes in lymphocyte development and function. Nat Immunol 5(2):133–139. doi:10.1038/ni1033
4. Naylor K, Li G, Vallejo AN, Lee WW, Koetz K, Bryl E, Witkowski J, Fulbright J, Weyand CM, Goronzy JJ (2005) The influence of age on T cell generation and TCR diversity. J Immunol 174(11):7446–7452. doi:10.4049/jimmunol.174.11.7446
5. Manser AR, Weinhold S, Uhrberg M (2015) Human KIR repertoires: shaped by genetic diversity and evolution. Immunol Rev 267. doi:10.1111/imr.12316
6. Weng NP (2006) Aging of the immune system: how much can the adaptive immune system adapt? Immunity 24(5):495–499. doi:10.1016/j.immuni.2006.05.001
7. Le Garff-Tavernier M, Beziat V, Decocq J, Siguret V, Gandjbakhch F, Pautas E, Debre P, Merle-Beral H, Vieillard V (2010) Human NK cells display major phenotypic and functional changes over the life span. Aging Cell 9(4):527–535. doi:10.1111/j.1474-9726.2010.00584.x
8. Almeida-Oliveira A, Smith-Carvalho M, Porto LC, Cardoso-Oliveira J, Ribeiro Ados S, Falcao RR, Abdelhay E, Bouzas LF, Thuler LC, Ornellas MH, Diamond HR (2011) Age-related changes in natural killer cell receptors from childhood through old age. Hum Immunol 72(4):319–329. doi:10.1016/j.humimm.2011.01.009
9. Hazeldine J, Hampson P, Lord JM (2012) Reduced release and binding of perforin at the immunological synapse underlies the age-related decline in natural killer cell cytotoxicity. Aging Cell 11(5):751–759. doi:10.1111/j.1474-9726.2012.00839.x
10. Lutz CT, Karapetyan A, Al-Attar A, Shelton BJ, Holt KJ, Tucker JH, Presnell SR (2011) Human NK cells proliferate and die in vivo more rapidly than T cells in healthy young and elderly adults. J Immunol 186(8):4590–4598. doi:10.4049/jimmunol.1002732
11. Lutz CT, Moore MB, Bradley S, Shelton BJ, Lutgendorf SK (2005) Reciprocal age related change in natural killer cell receptors for MHC class I. Mech Ageing Dev 126(6–7):722–731. doi:10.1016/j.mad.2005.01.004
12. Campos C, Pera A, Sanchez-Correa B, Alonso C, Lopez-Fernandez I, Morgado S, Tarazona R, Solana R (2014) Effect of age and CMV on NK cell subpopulations. Exp Gerontol 54:130–137. doi:10.1016/j.exger.2014.01.008
13. bright NK cells. Immun Ageing 3:10. doi:10.1186/1742-4933-3-10
14. Uhrberg M (2005) The CD107 mobilization assay: viable isolation and immunotherapeutic potential of tumor-cytolytic NK cells. Leukemia 19(5):707–709. doi:10.1038/sj.leu.2403705
15. dim NK-cell differentiation uncoupled from NK-cell education. Blood 116(19):3853–3864. doi:10.1182/blood-2010-04-281675
16. Beziat V, Descours B, Parizot C, Debre P, Vieillard V (2010) NK cell terminal differentiation: correlated stepwise decrease of NKG2A and acquisition of KIRs. PLoS One 5(8):e11966. doi:10.1371/journal.pone.0011966
17. dimCD16 + NK-cell subset. Blood 116(19):3865–3874. doi:10.1182/blood-2010-04-282301
18. Juelke K, Killig M, Thiel A, Dong J, Romagnani C (2009) Education of hyporesponsive NK cells by cytokines. Eur J Immunol 39(9):2548–2555. doi:10.1002/eji.200939307
19. Campos C, Lopez N, Pera A, Gordillo JJ, Hassouneh F, Tarazona R, Solana R (2015) Expression of NKp30, NKp46 and DNAM-1 activating receptors on resting and IL-2 activated NK cells from healthy donors according to CMV-serostatus and age. Biogerontology. doi:10.1007/s10522-015-9581-0
20. Ferlazzo G, Thomas D, Lin SL, Goodman K, Morandi B, Muller WA, Moretta A, Munz C (2004) The abundant NK cells in human secondary lymphoid tissues require activation to express killer cell Ig-like receptors and become cytolytic. J Immunol 172(3):1455–1462. doi:10.4049/jimmunol.172.3.1455
21. Nagler A, Lanier LL, Cwirla S, Phillips JH (1989) Comparative studies of human FcRIII-positive and negative natural killer cells. J Immunol 143(10):3183–3191
22. Hejazi M, Manser AR, Frobel J, Kundgen A, Zhao X, Schonberg K, Germing U, Haas R, Gattermann N, Uhrberg M (2015) Impaired cytotoxicity associated with defective natural killer cell differentiation in myelodysplastic syndromes. Haematologica 100(5):643–652. doi:10.3324/haematol.2014.118679
23. Cooper MA, Fehniger TA, Turner SC, Chen KS, Ghaheri BA, Ghayur T, Carson WE, Caligiuri MA (2001) Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset. Blood 97(10):3146–3151
24. dim NK cells upon activation. J Immunol 178(8):4947–4955. doi:10.4049/jimmunol.178.8.4947
25. Mariani E, Meneghetti A, Formentini I, Neri S, Cattini L, Ravaglia G, Forti P, Facchini A (2003) Different rates of telomere shortening and telomerase activity reduction in CD8 T and CD16 NK lymphocytes with ageing. Exp Gerontol 38(6):653–659. doi:10.1016/S0531-5565(03)00058-5
26. Beli E, Duriancik DM, Clinthorne JF, Lee T, Kim S, Gardner EM (2014) Natural killer cell development and maturation in aged mice. Mech Ageing Dev 135:33–40. doi:10.1016/j.mad.2013.11.007
27. Shehata HM, Hoebe K, Chougnet CA (2015) The aged nonhematopoietic environment impairs natural killer cell maturation and function. Aging Cell 14(2):191–199. doi:10.1111/acel.12303
28. Parham P, Norman PJ, Abi-Rached L, Guethlein LA (2012) Human-specific evolution of killer cell immunoglobulin-like receptor recognition of major histocompatibility complex class I molecules. Philos Trans R Soc Lond B Biol Sci 367(1590):800–811. doi:10.1098/rstb.2011.0266
29. Uhrberg M (2005) The KIR gene family: life in the fast lane of evolution. Eur J Immunol 35(1):10–15. doi:10.1002/eji.200425743
30. Uhrberg M (2005) Shaping the human NK cell repertoire: an epigenetic glance at KIR gene regulation. Mol Immunol 42(4):471–475. doi:10.1016/j.molimm.2004.07.029
31. Borrego F, Ulbrecht M, Weiss EH, Coligan JE, Brooks AG (1998) Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis. J Exp Med 187(5):813–818. doi:10.1084/jem.187.5.813
32. Braud VM, Allan DS, O’Callaghan CA, Soderstrom K, D’Andrea A, Ogg GS, Lazetic S, Young NT, Bell JI, Phillips JH, Lanier LL, McMichael AJ (1998) HLA-E binds to natural killer cell receptors CD94/NKG2A. B and C. Nature 391(6669):795–799. doi:10.1038/35869
33. Lee N, Llano M, Carretero M, Ishitani A, Navarro F, Lopez-Botet M, Geraghty DE (1998) HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A. Proc Natl Acad Sci USA 95(9):5199–5204. doi:10.1073/pnas.95.9.5199
34. Bauer S, Groh V, Wu J, Steinle A, Phillips JH, Lanier LL, Spies T (1999) Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 285(5428):727–729. doi:10.1126/science.285.5428.727
35. Cosman D, Mullberg J, Sutherland CL, Chin W, Armitage R, Fanslow W, Kubin M, Chalupny NJ (2001) ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor. Immunity 14(2):123–133. doi:10.1016/S1074-7613(01)00095-4
36. Kim S, Poursine-Laurent J, Truscott SM, Lybarger L, Song YJ, Yang L, French AR, Sunwoo JB, Lemieux S, Hansen TH, Yokoyama WM (2005) Licensing of natural killer cells by host major histocompatibility complex class I molecules. Nature 436(7051):709–713. doi:10.1038/nature03847
37. Fernandez NC, Treiner E, Vance RE, Jamieson AM, Lemieux S, Raulet DH (2005) A subset of natural killer cells achieves self-tolerance without expressing inhibitory receptors specific for self-MHC molecules. Blood 105(11):4416–4423. doi:10.1182/blood-2004-08-3156
38. Anfossi N, Andre P, Guia S, Falk CS, Roetynck S, Stewart CA, Breso V, Frassati C, Reviron D, Middleton D, Romagne F, Ugolini S, Vivier E (2006) Human NK cell education by inhibitory receptors for MHC class I. Immunity 25(2):331–342. doi:10.1016/j.immuni.2006.06.013
39. Bienemann K, Iouannidou K, Schoenberg K, Krux F, Reuther S, Feyen O, Bienemann K, Schuster F, Uhrberg M, Laws HJ, Borkhardt A (2011) iNKT cell frequency in peripheral blood of Caucasian children and adolescent: the absolute iNKT cell count is stable from birth to adulthood. Scand J Immunol 74(4):406–411. doi:10.1111/j.1365-3083.2011.02591.x
40. Schonberg K, Fischer JC, Kogler G, Uhrberg M (2011) Neonatal NK-cell repertoires are functionally, but not structurally, biased toward recognition of self HLA class I. Blood 117(19):5152–5156. doi:10.1182/blood-2011-02-334441
41. Schonberg K, Sribar M, Enczmann J, Fischer JC, Uhrberg M (2011) Analyses of HLA-C-specific KIR repertoires in donors with group A and B haplotypes suggest a ligand-instructed model of NK cell receptor acquisition. Blood 117(1):98–107. doi:10.1182/blood-2010-03-273656
42. Phillips JH, Lanier LL (1985) A model for the differentiation of human natural killer cells. Studies on the in vitro activation of Leu-11 + granular lymphocytes with a natural killer-sensitive tumor cell, K562. J Exp Med 161(6):1464–1482
43. Nikolich-Zugich J (2008) Ageing and life-long maintenance of T-cell subsets in the face of latent persistent infections. Nat Rev Immunol 8(7):512–522. doi:10.1038/nri2318
44. Pawelec G, McElhaney JE, Aiello AE, Derhovanessian E (2012) The impact of CMV infection on survival in older humans. Curr Opin Immunol 24(4):507–511. doi:10.1016/j.coi.2012.04.002
45. Guma M, Angulo A, Vilches C, Gomez-Lozano N, Malats N, Lopez-Botet M (2004) Imprint of human cytomegalovirus infection on the NK cell receptor repertoire. Blood 104(12):3664–3671. doi:10.1182/blood-2004-05-2058
46. Arase H, Mocarski ES, Campbell AE, Hill AB, Lanier LL (2002) Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science 296(5571):1323–1326. doi:10.1126/science.1070884
47. Beziat V, Liu LL, Malmberg JA, Ivarsson MA, Sohlberg E, Bjorklund AT, Retiere C, Sverremark-Ekstrom E, Traherne J, Ljungman P, Schaffer M, Price DA, Trowsdale J, Michaelsson J, Ljunggren HG, Malmberg KJ (2013) NK cell responses to cytomegalovirus infection lead to stable imprints in the human KIR repertoire and involve activating KIRs. Blood 121(14):2678–2688. doi:10.1182/blood-2012-10-459545
48. Bjorkstrom NK, Lindgren T, Stoltz M, Fauriat C, Braun M, Evander M, Michaelsson J, Malmberg KJ, Klingstrom J, Ahlm C, Ljunggren HG (2010) Rapid expansion and long-term persistence of elevated NK cell numbers in humans infected with hantavirus. J Exp Med 208(1):13–21. doi:10.1084/jem.20100762
49. Beziat V, Dalgard O, Asselah T, Halfon P, Bedossa P, Boudifa A, Hervier B, Theodorou I, Martinot M, Debre P, Bjorkstrom NK, Malmberg KJ, Marcellin P, Vieillard V (2012) CMV drives clonal expansion of NKG2C + NK cells expressing self-specific KIRs in chronic hepatitis patients. Eur J Immunol 42(2):447–457. doi:10.1002/eji.201141826
50. Guma M, Cabrera C, Erkizia I, Bofill M, Clotet B, Ruiz L, Lopez-Botet M (2006) Human cytomegalovirus infection is associated with increased proportions of NK cells that express the CD94/NKG2C receptor in aviremic HIV-1-positive patients. J Infect Dis 194(1):38–41. doi:10.1086/504719
51. Elmaagacli AH, Steckel NK, Koldehoff M, Hegerfeldt Y, Trenschel R, Ditschkowski M, Christoph S, Gromke T, Kordelas L, Ottinger HD, Ross RS, Horn PA, Schnittger S, Beelen DW (2011) Early human cytomegalovirus replication after transplantation is associated with a decreased relapse risk: evidence for a putative virus-versus-leukemia effect in acute myeloid leukemia patients. Blood 118(5):1402–1412. doi:10.1182/blood-2010-08-304121
52. Germing U, Aul C, Niemeyer CM, Haas R, Bennett JM (2008) Epidemiology, classification and prognosis of adults and children with myelodysplastic syndromes. Ann Hematol 87(9):691–699. doi:10.1007/s00277-008-0499-3
53. Geyh S, Oz S, Cadeddu RP, Frobel J, Bruckner B, Kundgen A, Fenk R, Bruns I, Zilkens C, Hermsen D, Gattermann N, Kobbe G, Germing U, Lyko F, Haas R, Schroeder T (2013) Insufficient stromal support in MDS results from molecular and functional deficits of mesenchymal stromal cells. Leukemia 27(9):1841–1851. doi:10.1038/leu.2013.193
54. Chiu BC, Martin BE, Stolberg VR, Chensue SW (2013) The host environment is responsible for aging-related functional NK cell deficiency. J Immunol 191(9):4688–4698. doi:10.4049/jimmunol.1301625
55. Imai K, Matsuyama S, Miyake S, Suga K, Nakachi K (2000) Natural cytotoxic activity of peripheral-blood lymphocytes and cancer incidence: an 11-year follow-up study of a general population. Lancet 356(9244):1795–1799. doi:10.1016/S0140-6736(00)03231-1
56. Zhang Y, Wallace DL, de Lara CM, Ghattas H, Asquith B, Worth A, Griffin GE, Taylor GP, Tough DF, Beverley PC, Macallan DC (2007) In vivo kinetics of human natural killer cells: the effects of ageing and acute and chronic viral infection. Immunology 121(2):258–265. doi:10.1111/j.1365-2567.2007.02573.x